[go: up one dir, main page]

GB202004717D0 - Stabilisation of cell populations - Google Patents

Stabilisation of cell populations

Info

Publication number
GB202004717D0
GB202004717D0 GBGB2004717.1A GB202004717A GB202004717D0 GB 202004717 D0 GB202004717 D0 GB 202004717D0 GB 202004717 A GB202004717 A GB 202004717A GB 202004717 D0 GB202004717 D0 GB 202004717D0
Authority
GB
United Kingdom
Prior art keywords
stabilisation
cell populations
populations
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2004717.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Aberdeen
Original Assignee
University of Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Aberdeen filed Critical University of Aberdeen
Priority to GBGB2004717.1A priority Critical patent/GB202004717D0/en
Publication of GB202004717D0 publication Critical patent/GB202004717D0/en
Priority to PCT/EP2021/058045 priority patent/WO2021198114A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/72—Undefined extracts from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/05—Adjuvants
    • C12N2501/052—Lipopolysaccharides [LPS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB2004717.1A 2020-03-31 2020-03-31 Stabilisation of cell populations Ceased GB202004717D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2004717.1A GB202004717D0 (en) 2020-03-31 2020-03-31 Stabilisation of cell populations
PCT/EP2021/058045 WO2021198114A1 (en) 2020-03-31 2021-03-26 Stabilisation of cell populations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2004717.1A GB202004717D0 (en) 2020-03-31 2020-03-31 Stabilisation of cell populations

Publications (1)

Publication Number Publication Date
GB202004717D0 true GB202004717D0 (en) 2020-05-13

Family

ID=70553565

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2004717.1A Ceased GB202004717D0 (en) 2020-03-31 2020-03-31 Stabilisation of cell populations

Country Status (2)

Country Link
GB (1) GB202004717D0 (en)
WO (1) WO2021198114A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4532698A1 (en) * 2022-06-01 2025-04-09 Ecole Polytechnique Fédérale de Lausanne (EPFL) Engineered progenitor cells and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201790883A1 (en) * 2014-10-22 2018-02-28 Сотио А.С. TOLEROGENIC DENDRITIC CELLS, METHODS OF THEIR RECEIVING AND THEIR APPLICATION
US11643691B2 (en) * 2018-04-13 2023-05-09 Duke University Predictive biomarkers for cancer immunotherapy and methods of using same

Also Published As

Publication number Publication date
WO2021198114A1 (en) 2021-10-07

Similar Documents

Publication Publication Date Title
IL290538A (en) Ex vivo gamma delta t cell populations
GB2595415B (en) Compensation of own voice occlusion
GB202005216D0 (en) Cell
GB202007321D0 (en) T cells
IL307501A (en) Modified mammalian cells
GB201911958D0 (en) Methods of t cell production
ZA202211411B (en) Cell
GB202219480D0 (en) Cell Culture Construct
KR102423280B9 (en) Sot-mram area-optimized design of sot-mram
GB202012839D0 (en) Plasmid stabilisation
GB202004717D0 (en) Stabilisation of cell populations
GB202008642D0 (en) Electrohemical cell
GB202209920D0 (en) Cell
GB202018651D0 (en) Lithium-selenium cell
GB201914235D0 (en) Cell populations and methods of preparing same
GB202103774D0 (en) Detectiion of Ransomware
IL311786A (en) Hypoimmune cells
GB202102235D0 (en) Cell transplantation
GB202002073D0 (en) Horizontal cells
ES3054318T3 (en) Arrangement comprising an electrolytic cell
IL278384B1 (en) Optimization of nk-92 cell growth using poloxamer
GB202012172D0 (en) Gamma delta cell populations
GB202007178D0 (en) Bycical stabilisation
GB202111169D0 (en) Methods of T cell production
HK40077225A (en) Ex vivo gamma delta t cell populations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)